The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
SARS-CoV-2 evolution during treatment of chronic infection
Open accessPublished version of a preprint
Abstract
The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for virus infection through the engagement of the human ACE2 protein 1 and is a major antibody target. Here we show that chronic infection with SARS-CoV-2 leads to viral evolution and reduced sensitivity to neutralizing antibodies in an immunosuppressed individual treated with convalescent plasma, by generating whole-genome ultra-deep sequences for 23 time points that span 101 days and using in vitro techniques to characterize the mutations revealed by sequencing. There was little change in the overall structure of the viral population after two courses of remdesivir during the first 57 days. However, after convalescent plasma therapy, we observed large, dynamic shifts in the viral population, with the emergence of a dominant viral strain that contained a substitution (D796H) in the S2 subunit and a deletion (ΔH69/ΔV70) in the S1 N-terminal domain of the spike protein. As passively transferred serum antibodies diminished, viruses with the escape genotype were reduced in frequency, before returning during a final, unsuccessful course of convalescent plasma treatment. In vitro, the spike double mutant bearing both ΔH69/ΔV70 and D796H conferred modestly decreased sensitivity to convalescent plasma, while maintaining infectivity levels that were similar to the wild-type virus.The spike substitution mutant D796H appeared to be the main contributor to the decreased susceptibility to neutralizing antibodies, but this mutation resulted in an infectivity defect. The spike deletion mutant ΔH69/ΔV70 had a twofold higher level of infectivity than wild-type SARS-CoV-2, possibly compensating for the reduced infectivity of the D796H mutation. These data reveal strong selection on SARS-CoV-2 during convalescent plasma therapy, which is associated with the emergence of viral variants that show evidence of reduced susceptibility to neutralizing antibodies in immunosuppressed individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The possible theories about the origin of novel variants are the evolution of circulating intermediate mutants in the chronically infected immunocompromised patients supporting high viral replication while on treatment with immune plasma or monoclonal antibodies [88, 89].”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [89]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Previous studies showed that the binding affinity of SARS-CoV for human ACE2 correlated with the rate of viral replication in distinct species, transmissibility and disease severity 29–31.”
From Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies (2021) · cites this paper as [31]
Experimental — accuracy not yet measuredIn the citing paper
“The recent emergence of B.1.1.7,B.1.351and P.1 marks the beginning of SARS-CoV-2 antigenic drift.”
From Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 (2021) · cites this paper as [44]
In the citing paper
“Interestingly, repeated use of plasma therapy in an immunocompromised individual led to the transient emergence of the N501Y mutation as well as the 69–70 deletion in the NTD, which is characteristic of B.1.1.7 (Kemp et al., 2021).”
From Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera (2021) · cites this paper as Kemp et al., 2021
In the citing paper
“The B.1.1.7 variant emerged in the United Kingdom, the B.1.351variant (also termed 501Y.V2) in South Africa and the P.1 and P.2 lineages in Brazil 2,3,5,9-12 .”
From Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies (2021) · cites this paper as [3]
In the citing paper
“Although distinct, the variants share common characteristics, including known escape mutations that were previously identified under antibody pressure selection in vitro 2,3,[13][14][15][16][17] .”
From Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies (2021) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209
Cutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
ModelFinder: fast model selection for accurate phylogenetic estimates
Kalyaanamoorthy, S., Minh, B. Q., Wong, T. K. F., von Haeseler, A., & Jermiin, L. S. (2017) · Nature Methods · doi:10.1038/nmeth.4285 · Cited by 18,449
IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era
(2019) · doi:10.1101/849372 · Cited by 16,873
IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
Minh, B. Q., Schmidt, H. A., Chernomor, O., Schrempf, D., Woodhams, M. D., von Haeseler, A., & Lanfear, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa015 · Cited by 16,873
Minimap2: Pairwise alignment for nucleotide sequences
Li, H. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty191 · Cited by 14,807
BEAST 2: a software platform for Bayesian evolutionary analysis
Bouckaert, R., Heled, J., Kühnert, D., Vaughan, T., Wu, C.-H., Xie, D., Suchard, M. A., Rambaut, A., & Drummond, A. J. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003537 · Cited by 6,527
Ultrafast Approximation for Phylogenetic Bootstrap
Minh, B. Q., Nguyen, M. A. T., & von Haeseler, A. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst024 · Cited by 4,844
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Research works printed but not linked: 2
- Rambaut, A. et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Preprint at https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 (2020).
- Meredith, L. W. et al. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study. Lancet Infect. Dis. 20, 1263–1271 (2020). · DOI
Cited by
Sorted by citations
Items 401–500 of 1,006
Incomplete immunity in a natural animal-microbiota interaction selects for higher pathogen virulence
Hoang, K. L., Read, T. D., & King, K. C. (2024) · Current Biology · doi:10.1016/j.cub.2024.02.015 · Cited by 24
“44 The initial lower pathogen load in immune-primed hosts (Figure 1B) may also dampen the number of new mutations that can be acquired in these populations.”
Dudas, G., Hong, S. L., Potter, B., Calvignac-Spencer, S., Niatou-Singa, F. S., Tombolomako, T. B., Fuh-Neba, T., Vickos, U., Ulrich, M., Leendertz, F. H., et al. (2021) · doi:10.1101/2021.05.04.21256637 · Cited by 76
COVID‐19: emergence and mutational diversification of SARS‐CoV‐2
Brüssow, H. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13800 · Cited by 23
Palomba, E., Carrabba, M., Zuglian, G., Alagna, L., Saltini, P., Fortina, V., Hu, C. M., Bandera, A., Fabio, G., Gori, A., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.07.064 · Cited by 22
“As reported by Kemp et al. (2021) , prolonged therpy with convalescent plasma can trigger an evolutionary response y SARS-CoV-2, resulting in the selection of viral variants with reuced sensitivity to neutralizing antibodies.”
BackgroundApplication of omics technology to combat the COVID‐19 pandemic
Yang, J., Yan, Y., & Zhong, W. (2021) · MedComm · doi:10.1002/mco2.90 · Cited by 20
SARS-CoV-2 Infection of Rhesus Macaques Treated Early with Human COVID-19 Convalescent Plasma
Deere, J. D., Carroll, T. D., Dutra, J., Fritts, L., Sammak, R. L., Yee, J. L., Olstad, K. J., Reader, J. R., Kistler, A. L., Kamm, J., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01397-21 · Cited by 19
AIDS patient with severe T cell depletion achieved control but not clearance of SARS‐CoV‐2 infection
Spinicci, M., Mazzoni, A., Borchi, B., Graziani, L., Mazzetti, M., Bartalesi, F., Botta, A., Tilli, M., Pieralli, F., Coppi, M., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202149574 · Cited by 21
Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
Damavandi, A. R., Dowran, R., Sharif, S. A., Kashanchi, F., & Jafari, R. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00729-6 · Cited by 21
“Despite these inherent abilities, vaccination may hamper the diversity of escape mutations [23], whereas convalescent plasma therapy of immunocompetent individuals with chronic infection may be attributed to the emergence of new mutants with resistance to the neutralizing antibodies [24].”
BackgroundKarsten, H., Cords, L., Westphal, T., Knapp, M., Brehm, T. T., Hermanussen, L., Omansen, T. F., Schmiedel, S., Woost, R., Ditt, V., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1410 · Cited by 21
Orf, G. S., Olivo, A., Harris, B., Weiss, S. L., Achari, A., Yu, G., Federman, S., Mbanya, D., James, L., Mampunza, S. M. M., et al. (2023) · Viruses · doi:10.3390/v15041022 · Cited by 21
“Examples include the accumulation of escape immune mutations during chronic SARS-CoV-2 infection of an immunocompromised cancer patient [12] and reactivation of latent herpesviruses in organ transplant recipients [13].”
BackgroundPerevaryukha, A. Y. (2023) · BIOPHYSICS · doi:10.1134/s0006350923050202 · Cited by 21
Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike
Tan, T. J. C., Verma, A. K., Odle, A. E., Lei, R., Meyerholz, D. K., Matreyek, K. A., Perlman, S. M., Wong, L.-Y. R., & Wu, N. C. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317222121 · Cited by 21
“A pre vious study has shown that S2 mutation D796H, which locates near the base of the S protein and emerged in a chronically infected patient, reduces sensitivity to neutralization by convalescent plasma (41).”
BackgroundAssessing the risk of vaccine-driven virulence evolution in SARS-CoV-2
Miller, I. F., & Metcalf, C. J. E. (2022) · Royal Society Open Science · doi:10.1098/rsos.211021 · Cited by 22
Spinicci, M., Mazzoni, A., Coppi, M., Antonelli, A., Salvati, L., Maggi, L., Basile, G., Graziani, L., Lauria, N. D., Pilato, V. D., et al. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01313-6 · Cited by 19
Effect of SARS-CoV-2 spike mutations on animal ACE2 usage and in vitro neutralization sensitivityPreprint
Yao, W., Ma, D., Wang, H., Tang, X., Du, C., Pan, H., Li, C., Lin, H., Farzan, M., Zhao, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.27.428353 · Cited by 21
Xiao, C., Mao, L., Wang, Z., Gao, L., Zhu, G., Su, J., Chen, X., Yuan, J., Hu, Y., Yin, Z., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103934 · Cited by 21
Wang, Y., Sun, H. J., Xu, G., Guan, M., Zhang, Q., Wang, Z., Dong, Z., Chen, W., Yang, X., Anbang, Q., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114496 · Cited by 20
SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients
Lee, J., Yun, K. W., Jeong, H., Kim, B., Kim, M. J., Park, J. H., Shin, H. S., Oh, H. S., Sung, H., Song, M. G., et al. (2022) · Virulence · doi:10.1080/21505594.2022.2101198 · Cited by 18
“which may encourage viral evolution [11].”
Self-citationTian, D., Nie, W., Sun, Y., & Ye, Q. (2022) · Vaccines · doi:10.3390/vaccines10101699 · Cited by 20
Burkholz, S., Pokhrel, S., Kraemer, B. R., Mochly‐Rosen, D., Carback, R. T., Hodge, T., Harris, P. E., Ciotlos, S., Wang, L., Herst, C. V., et al. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104897 · Cited by 20
Richard, D., Shaw, L. P., Lanfear, R., Corbett-Detig, R. B., Hinrichs, A. S., McBroome, J., Turakhia, Y., Acman, M., Owen, C. J., Tan, C. C. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.06.442903 · Cited by 20
The unique evolutionary dynamics of the SARS-CoV-2 Delta variantPreprint
Stern, A., Fleishon, S., Kustin, T., Dotan, E., Mandelboim, M., Erster, O., Mendelson, E., Mor, O., & Zuckerman, N. S. (2021) · medRxiv · doi:10.1101/2021.08.05.21261642 · Cited by 23
“It has been previously observed that during treatment of such individuals with convalescent plasma or with monoclonal antibodies, rapid evolution is observed, including the accumulation of various Spike amino-acid replacements that are prevalent in VOs [18].”
BackgroundLista, M. J., Winstone, H., Wilson, H., Dyer, A. S., Pickering, S., Galão, R. P., Lorenzo, G. D., Cowton, V. M., Furnon, W., Suárez, N. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.09.467693 · Cited by 20
Self-citationAbbas, Q., Викторович, К. А., Sharrouf, K. A., Jyakhwo, S., & Komissarov, A. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.25.481941 · Cited by 19
“3] Appeared a few times independently [30,85], including a case of intra-host evolution in a immunocompromised (HIV) patient [27].”
BackgroundInfluentialBaker, D., MacDougall, A. M., Kang, A. S., Schmierer, K., Giovannoni, G., & Dobson, R. (2021) · Clinical & Experimental Immunology · doi:10.1093/cei/uxab015 · Cited by 21
Self-citationPersistent SARS-CoV-2 infection in asymptomatic young adults
Ma, M., Qiu, S., Cui, X., Ni, M., Liu, H., Ye, R., Yao, L., Liu, H., Cao, W., & Song, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00931-1 · Cited by 21
“Moreover, persistent SARS-CoV-2 infection within immunocompromised individuals could accumulate more mutations during convalescent plasma therapy with evidence of reduced susceptibility to neutralizing antibodies.(6) However, the temporal dynamics of SARS-CoV-2 infectivity and the evolution of SARS-CoV-2 mutational pr…”
BackgroundSARS-CoV-2 Vaccination and the Bridge between First and Fourth Dose: Where Are We?
Stasi, C., Meoni, B., Voller, F., & Silvestri, C. (2022) · Vaccines · doi:10.3390/vaccines10030444 · Cited by 20
“Considering the viral dynamics and viral evolution in response to different selection pressures in an immunocompromised individual, one hypothesis of the emergence of the Alpha variant was that it accumulated many mutations within a chronically infected immunocompromised patient [19].”
BackgroundBeydon, M., Nicaise‐Roland, P., Mageau, A., Farkh, C., Daugas, É., Descamps, V., Dieudé, P., Dossier, A., Goulenok, T. M., Farhi, F., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15508-9 · Cited by 19
Monoclonal antibodies for prophylaxis and treatment of respiratory viral infections
Boonyaratanakornkit, J. B., Boeckh, M., & Waghmare, A. (2022) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000846 · Cited by 19
Evaluating the impact of COVID ‐19 on cancer declarations in Quebec, Canada
Ramanakumar, A. V., Annie, B., Lamonde, F., Christine, B., Cathy, R., & Latreille, J. (2022) · Cancer Medicine · doi:10.1002/cam4.5389 · Cited by 18
Intra-Host Evolution Provides for Continuous Emergence of SARS-CoV-2 Variants
Landis, J. T., Moorad, R., Pluta, L., Caro‐Vegas, C., McNamara, R. P., Eason, A. B., Bailey, A., Villamor, F. C. S., Juarez, A., Wong, J. P., et al. (2021) · mBio · doi:10.1128/mbio.03448-22 · Cited by 20
Serwanga, J., Ankunda, V., Sembera, J., Kato, L., Oluka, G. K., Baine, C., Odoch, G., Kayiwa, J. T., Auma, B. O., Jjuuko, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152522 · Cited by 20
Dynamical modelling of viral infection and cooperative immune protection in COVID-19 patients
Zhou, Z., Li, D., Zhao, Z., Shi, S., Wu, J., Li, J., Zhang, J., Gui, K., Zhang, Y. L., Ouyang, Q., et al. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011383 · Cited by 17
“Meanwhile, Mode 4 patients are severe or critical care patients with chronic infection which most notably occurs in immunocompromised cases [66,67] and the elderly [60] For instance, the extent of tissue damage in Mode 1 and 2 is milder than that in Mode 3 and 4, and adaptive immunity in Mode 4,…”
SARS‐CoV‐2 persistence in immunocompromised children
Dolan, S. A., Levy, J. M. M., Moss, A. F. D., Pearce, K., Butler, M., Jung, S. A., Dominguez, S. R., Mwangi, E., Maloney, K. W., & Rao, S. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29277 · Cited by 19
Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
Woopen, C., Schleußner, K., Akgün, K., & Ziemssen, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701752 · Cited by 20
“Notably, immunocompromised patients may be confronted with the hazard of viral escape mutations during chronic SARS-CoV-2 infection (33).”
BackgroundBradley, R. E., Ponsford, M., Scurr, M. J., Godkin, A. J., Jolles, S. R. A., Bramhall, K., Price, C. R., Evans, K., Carne, E. M., El‐Shanawany, T., et al. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01158-5 · Cited by 18
Guisado‐Vasco, P., Carralón-González, M. M., Aguareles, J., Martí-Ballesteros, E. M., Sánchez-Manzano, M., Carnevali-Ruiz, D., García-Coca, M., Barrena-Puertas, R., LaPetra, R. G. D. V., Luque-Pinilla, J. M., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01220-0 · Cited by 18
Severe Acute Respiratory Syndrome Type 2‐Causing Coronavirus: Variants and Preventive Strategies
Aydoğdu, M. O., Rohn, J. L., Jafari, N. V., Brako, F., Homer‐Vanniasinkam, S., & Edirisinghe, M. J. (2022) · Advanced Science · doi:10.1002/advs.202104495 · Cited by 18
Upadhyay, V., Patrick, C., Lucas, A., & Mallela, K. M. G. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00132 · Cited by 17
Stability and expression of SARS-CoV-2 spike-protein mutations
Bæk, K. T., Mehra, R., & Kepp, K. P. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04588-w · Cited by 17
Delta-Omicron recombinant escapes therapeutic antibody neutralization
Duerr, R., Zhou, H., Tada, T., Dimartino, D., Marier, C., Zappile, P., Wang, G., Plitnick, J., Griesemer, S. B., Girardin, R. C., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106075 · Cited by 18
“16,17 21 Overall, there is a lack of data on which underlying conditions and treatment pressures favor the selection of recombinant SARS-CoV-2 over their parental lineages.”
Molecular Epidemiology and Diversity of SARS-CoV-2 in Ethiopia, 2020–2022
Sisay, A., Tshiabuila, D., Tesfaye, A., Mboowa, G., Oyola, S. O., Tessema, S. K., Baxter, C., Martin, D., Lessells, R. J., Tegally, H., et al. (2023) · Genes · doi:10.3390/genes14030705 · Cited by 18
“This strategy was effective in slowing the 363 evolutionary rate of the virus as SARS-CoV-2 is prone to evolution in 364 immunosuppressed individuals experiencing chronic infection [42-44].”
MethodHarnessing aptamers against COVID-19: A therapeutic strategy
Mahmoudi, A. A., Alavizadeh, S. H., Hosseini, S. A., Meidany, P., Doagooyan, M., Abolhassani, Y., Saadat, Z., Amani, F., Kesharwani, P., Gheybi, F., et al. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103663 · Cited by 18
Pavia, G., Quirino, A., Marascio, N., Veneziano, C., Longhini, F., Bruni, A., Garofalo, E., Pantanella, M., Manno, M., Gigliotti, S., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29708 · Cited by 18
Yousefghahari, B., Navari, S., Sadeghi, M., Soleimaniamiri, S., Soleimaniamiri, M., Heidari, B., Babaei, M., Ghodrati, K., Guran, A., & Gholinia, H. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05779-4 · Cited by 18
Makdasi, E., Zvi, A., Alcalay, R., Noy-Porat, T., Peretz, E., Mechaly, A., Levy, Y., Epstein, E., Chitlaru, T., Tennenhouse, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109679 · Cited by 19
“Nevertheless, the rapid global spread of theSARS-CoV-2, possibly combinedwith selective pressure for immune escape (Kemp et al., 2021), enabled emergence of new SARS-CoV-2 variants.”
BackgroundRajpal, V. R., Sharma, S., Sehgal, D., Singh, A., Kumar, A., Vaishnavi, S., Tiwari, M., Bhalla, H., Goel, S., & Raina, S. N. (2022) · Future Virology · doi:10.2217/fvl-2021-0277 · Cited by 21
Pascall, D. J., Vink, E., Blacow, R., Bulteel, N., Campbell, A., Campbell, R., Clifford, S., Davis, C., Filipe, A. D. S., Sakka, N. E., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284187 · Cited by 18
“In addition, a deletion at position 69–70 may have increased virus infectivity [33].”
BackgroundSelf-citationGilliland, T. H., Liu, Y., Li, R., Dunn, M., Cottle, E. L., Terada, Y., Ryckman, Z., Alcorn, M. D. H., Vasilatos, S. N., Lundy, J. D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.26.453840 · Cited by 17
de Oliveira, V. M., da Rocha, M. N., Magalhães, E. P., Mendes, F. R. D. S., Marinho, M. M., de Menezes, R. R. P. P. B., Sampaio, T. L., dos Santos, H. S., Martins, A. M. C., & Marinho, E. S. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-021-00334-z · Cited by 17
Seneviratne, S. L., Wijerathne, W., Yasawardene, P. C., & Somawardana, B. (2022) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trac015 · Cited by 18
Morel, A., Imbeaud, S., Scemla, A., Péré, H., Fourgeaud, J., Amrouche, L., Robillard, N., Planas, D., Puech, J., Simon, S., et al. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17000 · Cited by 18
Niu, M., Han, Y., Dong, X., Yang, L., Li, F., Zhang, Y., Hu, Q., Xia, X., Li, H., & Sun, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.831332 · Cited by 17
“Amino acid mutation sites, such as N501Y, E484K, and HV69-70del cross-appear or appear simultaneously in multiple VOC and VOI variants, indicating that SARS-CoV-2 has undergone adaptive changes and evolution during the COVID-19 pandemic in the process of continuous adaptation to the host (Li Q. et al., 2021; Kemp et a…”
BackgroundCOVID and the Kidney: An Update
Bell, S., Perkins, G. B., Anandh, U., & Coates, P. T. (2023) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2023.151471 · Cited by 17
Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection
Ko, S. H., Radecki, P. E., Belinky, F., Bhiman, J. N., Meiring, S. T., Kleynhans, J., Amoako, D. G., Canedo, V. G., Lucas, M., Kekana, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51539-8 · Cited by 22
Picazo, J. J. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/085.2021 · Cited by 22
Chen, H., Li, Z., Feng, S., Richard‐Greenblatt, M., Hutson, E., Andrianus, S., Glaser, L. J., Rodino, K. G., Qian, J., Jayaraman, D., et al. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab158 · Cited by 17
Self-citationAvivi, I. M., Luttwak, E., Saiag, E., Halperin, T., Haberman, S., Sarig, A., Levi, S., Aharon, A., Herishanu, Y., & Perry, C. (2022) · British Journal of Haematology · doi:10.1111/bjh.18029 · Cited by 17
Cellular therapies for the treatment and prevention of SARS-CoV-2 infection
Conway, S. R., Keller, M. D., & Bollard, C. M. (2022) · Blood · doi:10.1182/blood.2021012249 · Cited by 17
Shah, M., Moon, S. U., Kim, J. H., Thao, T. T., & Woo, H. G. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.04.030 · Cited by 15
Sayed, A. M., Ibrahim, A. H., Tajuddeen, N., Seibel, J., Bodem, J., Geiger, N., Striffler, K., Bringmann, G., & Abdelmohsen, U. R. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115226 · Cited by 18
“Medical drugs currently in use are, so far, remdesivir, an antiviral agent that demonstrated benefits in decreasing the rate and the duration of hospitalization [12,13], and dexamethasone, a broad-spectrum anti-inflammatory drug offering assistance to patients with respiratory failure requiring respiratory support thr…”
Su, S., Shao, Y., & Jiang, S. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1896956 · Cited by 17
“Antibodies in convalescents and vaccinees may further exert selective pressure on wild-type SARS-CoV-2, resulting in complete escape of the virus from the current vaccines [14].”
BackgroundChronic SARS-CoV-2 infection and viral evolution in a hypogammaglobulinaemic individualPreprint
Williamson, M. K., Hamilton, F., Hutchings, S., Pymont, H. M., Hackett, M., Arnold, D., Maskell, N. A., MacGowan, A. P., Albur, M., Jenkins, M. H., et al. (2021) · medRxiv · doi:10.1101/2021.05.31.21257591 · Cited by 17
Self-citationCiuffreda, L., Lorenzo-Salazar, J. M., Alcoba-Flórez, J., Rodríguez‐Pérez, H., Gil-Campesino, H., Íñigo-Campos, A., de Artola, D. G.-M., Valenzuela-Fernández, A., Peraza, M. H., Rojo‐Alba, S., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.07.028 · Cited by 17
“Different constellations of mutations were observed in the sequences isolated from NP swab and BAL samples, suggesting the presence of compartmentalized viral subpopulations that evolved independently, as was previously suggested [2].”
BackgroundGenomic evidence for divergent co-infections of SARS-CoV-2 lineagesPreprint
Zhou, H., Cheng, Y., Xu, L. S., Li, J.-Y., Tao, C., Ji, C., Han, N., Yang, R., Li, Y., & Wu, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.03.458951 · Cited by 17
Yurkovetskiy, L., Egri, S. B., Kurhade, C., Díaz-Salinas, M. A., Jaimes, J. A., Nyalile, T., Xie, X., Choudhary, M. C., Dauphin, A., Li, J. Z., et al. (2023) · SSRN Electronic Journal · doi:10.1101/2023.03.30.535005 · Cited by 18
Courjon, J., Contenti, J., Demonchy, É., Levraut, J., Barbry, P., Rios, G., Dellamonica, J., Chirio, D., Bonnefoy, C., Giordanengo, V., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95067-7 · Cited by 19
Timofeeva, A. M., Sedykh, S. E., & Nevinsky, G. A. (2022) · Vaccines · doi:10.3390/vaccines10030384 · Cited by 17
How months-long COVID infections could seed dangerous new variants
Callaway, E. (2022) · Nature · doi:10.1038/d41586-022-01613-2 · Cited by 17
Hamdy, M. E., El‐Deeb, A. H., Hagag, N. M., Shahein, M. A., Alaidi, O., & Hussein, H. A. (2023) · International Journal of Veterinary Science and Medicine · doi:10.1080/23144599.2023.2222981 · Cited by 17
“● It is associated with immune evasion [85].”
BackgroundKugathasan, R., Sukhova, K., Moshe, M., Kellam, P., & Barclay, W. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011545 · Cited by 16
Meijer, S. E., Halutz, O., Adler, A., Levytskyi, K., Tau, L., Dekel, M., Cohen‐Poradosu, R., Katchman, E., Shasha, D., Ablin, J. N., et al. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.10.022 · Cited by 16
Shimazu, H., Wada, D., Maruyama, S., Inoue, A., Kashihara, M., Yoshihara, T., Saito, F., Yoshiya, K., Nakamori, Y., & Kuwagata, Y. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08797-6 · Cited by 16
Wang, D., Ge, Y., Zhong, B., & Liu, D. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.03.021 · Cited by 15
“In addition, as an RNA virus, the genome of SARS-CoV2 mutates easily which results in reduced sensitivity to neutralizing antibodies [27,28].”
Self-citationGenomic Epidemiology of SARS-CoV-2 in Pakistan
Song, S., Li, C., Kang, L., Tian, D., Badar, N., Ma, W., Zhao, S., Jiang, X., Wang, C., Sun, Y., et al. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.08.007 · Cited by 15
Li, J., Zhou, Z., Wang, Q., He, Q., Zhao, M., Qiu, Y., & Ge, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.770656 · Cited by 17
Antigenicity and infectivity characterization of SARS-CoV-2 BA.2.86Preprint
Yang, S., Yu, Y., Jian, F., Song, W., Yisimayi, A., Chen, X., Xu, Y., Wang, P., Wang, J., Yu, L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.01.555815 · Cited by 16
Kitamura, K., & Shimizu, H. (2021) · Viruses · doi:10.3390/v13071407 · Cited by 14
Muir, L., Jaffer, A., Rees-Spear, C., Gopalan, V., Chang, F. Y., Fernando, R., Vaitkute, G., Roustan, C., Rosa, A., Earl, C. P., et al. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.03.902 · Cited by 15
Self-citationKibria, K. M. K., Faruque, M. O., Islam, M. S. B., Ullah, H., Mahmud, S., Miah, M., & Saleh, A. A. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-11988-x · Cited by 16
“1985; Karplus and Schulz 1985; Kolaskar and Tongaonkar 1990; Parker et al.”
BackgroundMorita, R., Kubota‐Koketsu, R., Lu, X., Sasaki, T., Nakayama, E. E., Liu, Y., Okuzaki, D., Motooka, D., Wing, J. B., Fujikawa, Y., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106685 · Cited by 15
“3 3 10 4b Kemp et al.(12) Marginal B cell lymphoma 11.”
Lindahl, A. L., Ahava, M. J., Haukipää, M., Kreivi, H., Lipponen, A., & Kortela, E. (2023) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2023.2223274 · Cited by 15
Abdullahi, A., Frimpong, J. O., Cheng, M. T. K., Aliyu, S. H., Smith, C. J., Abimiku, A., Phillips, R. O., Owusu, M., & Gupta, R. K. (2023) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.23-0179 · Cited by 15
“As the SARS COV-2 pandemic continues, novel variants of concern with mutations enhancing transmissibility, replication, and immunity evasion capacity continue to emerge as observed in the Delta and Omicron variants,(15) deriving from chronic infections.(26) These novel variants may be associated with a difference in t…”
Self-citationChallenges in Emerging Vaccines and Future Promising Candidates against SARS‐CoV‐2 Variants
Ghildiyal, T., Rai, N., Rawat, J. M., Singh, M., Anand, J., Pant, G., Kumar, G., & Shidiki, A. (2024) · Journal of Immunology Research · doi:10.1155/2024/9125398 · Cited by 16
“Additionally, S protein deletions at positions 69 and 70 resulted in the failure of virus detection in the RT-PCR diagnostic tests and, hence, doubled the infectivity and cases worldwide [40, 41].”
BackgroundHuygens, S., GeurtsvanKessel, C. H., Gharbharan, A., Bogers, S., Worp, N., Boter, M., Bax, H. I., Kampschreur, L. M., Hassing, R., Fiets, R. B., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae026 · Cited by 15
Su, S., Wang, Q., & Jiang, S. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.284 · Cited by 14
Decision support for the quickest detection of critical COVID-19 phases
Braca, P., Gaglione, D., Marano, S., Millefiori, L. M., Willett, P., & Pattipati, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-86827-6 · Cited by 15
B-Cell Memory Responses to Variant Viral Antigens
White, H. N. (2021) · Viruses · doi:10.3390/v13040565 · Cited by 18
Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis
Gibson, E. G., Pender, M., Angerbauer, M., Cook, C., Jones, B. E., Spivak, A. M., Spivak, E. S., & Swaminathan, S. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab176 · Cited by 14
“sion, both with and without CCP treatment [4, 22].”
BackgroundImmunology of SARS-CoV-2 infections and vaccines
Schenten, D., & Bhattacharya, D. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.08.002 · Cited by 14
“…some of these patients, partial immune selec- tive pressure was applied through administration of convalescent plasma, all- owing for the emergence of transmissible and immune escape variants (Avanzato et al., 2020; Aydillo et al., 2020; Choi et al., 2020; Kemp et al., 2021; McCarthy et al., 2021).”
BackgroundImaging and visualizing SARS-CoV-2 in a new era for structural biology
Leigh, K. E., & Modis, Y. (2021) · Interface Focus · doi:10.1098/rsfs.2021.0019 · Cited by 17
Self-citationÁlvarez, H., Ruíz-Mateos, E., Juiz-González, P. M., Vitallé, J., Viéitez, I., Vázquez-Friol, M. D. C., Torres-Beceiro, I., Pérez-Gómez, A., Gallego‐García, P., Estévez‐Gómez, N., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10010143 · Cited by 15
Gachoud, D., Pillonel, T., Τσιλιμιδός, Γ., Battolla, D., Dumas, D., Opota, O., Fontana, S., Vollenweider, P., Manuel, O., Greub, G., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18450 · Cited by 13
Humoral immunity for durable control of SARS-CoV-2 and its variants
Kotaki, R., Moriyama, S., & Takahashi, Y. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00255-9 · Cited by 15
“Virus evolution has also been demonstrated in convalescent plasma treatment of an immunocompromised patient with persistent SARS-CoV-2 infection [42].”
BackgroundPeptides and peptidomimetics as therapeutic agents for Covid‐19
Dahal, A., Sonju, J. J., Kousoulas, K. G., & Jois, S. D. S. (2021) · Peptide Science · doi:10.1002/pep2.24245 · Cited by 14
Tegally, H., Ramuth, M., Amoaka, D., Scheepers, C., Wilkinson, E., Giovanetti, M., Lessells, R. J., Giandhari, J., Ismail, A., Martin, D. P., et al. (2021) · medRxiv · doi:10.1101/2021.06.16.21259017 · Cited by 13
Self-citationSARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
Drancourt, M., Cortaredona, S., Melenotte, C., Amrane, S., Eldin, C., Scola, B. L., Parola, P., Million, M., Lagier, J., Raoult, D., et al. (2021) · Viruses · doi:10.3390/v13050890 · Cited by 14
Variantes del SARS-CoV-2: epidemiología, fisiopatología y la importancia de las vacunas
Bedoya-Sommerkamp, M., Medina-Ranilla, J., Rodriguez, V. H. C., Li-Soldevilla, R., Vera-Albújar, Á., & Garcia, P. J. (2021) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2021.383.8734 · Cited by 13
Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19
Yegiazaryan, A., Abnousian, A., Alexander, L. J., Badaoui, A., Flaig, B., Sheren, N., Aghazarian, A., Alsaigh, D., Amin, A., Mundra, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169297 · Cited by 14
Roshdy, W. H., Khalifa, M. K., San, J. E., Tegally, H., Wilkinson, E., Showky, S., Martin, D. P., Moir, M., Naguib, A. M., Elguindy, N., et al. (2022) · Viruses · doi:10.3390/v14091878 · Cited by 12
“The sub-lineage also acquired the ∆HV69-70 deletion originally detected in the Alpha variant, which is associated with increased viral replication and infectivity [30,31].”
BackgroundSelf-citation
Metadata
- Authors
- Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., Roberts, D. J., Chandra, A., Temperton, N., The CITIID-NIHR BioResource COVID-19 Collaboration, Principal investigators, Baker, S., Dougan, G., Hess, C., Kingston, N., Lehner, P. J., Lyons, P. A., Matheson, N. J., Owehand, W. H., Saunders, C., Summers, C., Thaventhiran, J. E. D., Toshner, M., Weekes, M. P., nurses, C. &. V. R., Bucke, A., Calder, J., Canna, L., Domingo, J., Elmer, A., Fuller, S., Harris, J., Hewitt, S., Kennet, J., Jose, S., Kourampa, J., Meadows, A., O’Brien, C., Price, J., Publico, C., Rastall, R., Ribeiro, C., Rowlands, J., Ruffolo, V., Tordesillas, H., logistics, S., Bullman, B., Dunmore, B. J., Fawke, S., Gräf, S., Hodgson, J., Huang, C., Hunter, K., Jones, E., Legchenko, E., Matara, C., Martin, J., Mescia, F., O’Donnell, C., Pointon, L., Pond, N., Shih, J., Sutcliffe, R., Tilly, T., Treacy, C., Tong, Z., Wood, J., Wylot, M., acquisition, S. P. &. D., Bergamaschi, L., Betancourt, A., Bower, G., Cossetti, C., De Sa, A., Epping, M., Fawke, S., Gleadall, N., Grenfell, R., Hinch, A., Huhn, O., Jackson, S., Jarvis, I., Lewis, D., Marsden, J., Nice, F., Okecha, G., Omarjee, O., Perera, M., Richoz, N., Romashova, V., Yarkoni, N. S., Sharma, R., Stefanucci, L., Stephens, J., Strezlecki, M., Turner, L., collection, C. D., De Bie, E. M. D. D., Bunclark, K., Josipovic, M., Mackay, M., Rossi, S., Selvan, M., Spencer, S., Yong, C., Royal Papworth Hospital, I. C. U., Ansaripour, A., Michael, A., Mwaura, L., Patterson, C., Polwarth, G., Addenbrooke’s Hospital, I. C. U., Polgarova, P., di Stefano, G., Cambridge & Peterborough Foundation Trust, Fahey, C., Michel, R., ANPC & Centre for Molecular Medicine & Innovative Therapeutics, Bong, S.-H., Coudert, J. D., Holmes, E., BioResource, N., Allison, J., Butcher, H., Caputo, D., Clapham-Riley, D., Dewhurst, E., Furlong, A., Graves, B., Gray, J., Ivers, T., Kasanicki, M., Le Gresley, E., Linger, R., Meloy, S., Muldoon, F., Ovington, N., Papadia, S., Phelan, I., Stark, H., Stirrups, K. E., Townsend, P., Walker, N., Webster, J., The COVID-19 Genomics UK (COG-UK) Consortium, Funding acquisition, L. &. S., Robson, S. C., Funding acquisition, L. &. S., Loman, N. J., Connor, T. R., Leadership & supervision, M. C., Golubchik, T., Funding acquisition, M. C., Martinez Nunez, R. T., Funding acquisition, L. &. S., Ludden, C., Funding acquisition, L. &. S., Corden, S., Funding acquisition, L. &. S., Johnston, I., Bonsall, D., Funding acquisition, L. &. S., Smith, C. P., Awan, A. R., Funding acquisition, S. &. L., Bucca, G., Leadership & supervision, M. C., Estee Torok, M., Leadership & supervision, M. C., Saeed, K., Prieto, J. A., Leadership & supervision, M. C., Jackson, D. K., Metadata curation, P. A., Hamilton, W. L., Metadata curation, P. A., Snell, L. B., Funding acquisition, L. &. S., Moore, C., Funding acquisition, L. &. S., Harrison, E. M., Leadership & supervision, M. C., Goncalves, S., Leadership & supervision, M. C., Fairley, D. J., Loose, M. W., Watkins, J., Leadership & supervision, M. C., Livett, R., Leadership & supervision, M. C., Moses, S., Leadership & supervision, M. C., Amato, R., Nicholls, S., Bull, M., Leadership & supervision, P. A., Smith, D. L., Leadership & supervision, S. &. A., Barrett, J., Aanensen, D. M., Metadata curation, P. A., Curran, M. D., Parmar, S., Aggarwal, D., Shepherd, J. G., Metadata curation, P. A., Parker, M. D., Metadata curation, S. &. L., Glaysher, S., Metadata curation, S. &. A., Bashton, M., Underwood, A. P., Pacchiarini, N., Loveson, K. F., Project administration, S. &. A., Carabelli, A. M., Funding acquisition, L. &. S. A. M. C., Templeton, K. E., Funding acquisition, L. &. S. A. P. A., Langford, C. F., Sillitoe, J., de Silva, T. I., Wang, D., Funding acquisition, L. &. S. A. S. &. A., Kwiatkowski, D., Rambaut, A., O’Grady, J., Cottrell, S., Leadership & supervision, M. C. A. S. &. A., Holden, M. T. G., Thomson, E. C., Leadership & supervision, P. A. A. S. &. L., Osman, H., Andersson, M., Chauhan, A. J., Hassan-Ibrahim, M. O., Leadership & supervision, P. A. A. S. &. A., Lawniczak, M., Leadership & supervision, S. &. L. A. S. &. A., Alderton, A., Chand, M., Constantinidou, C., Unnikrishnan, M., Darby, A. C., Hiscox, J. A., Paterson, S., Leadership & supervision, S. &. A. A. S. &. A. T., Martincorena, I., Robertson, D. L., Volz, E. M., Page, A. J., Pybus, O. G., Leadership & supervision, S. &. A. A. V., Bassett, A. R., Metadata curation, P. A. A. S. &. L., Ariani, C. V., Spencer Chapman, M. H., Li, K. K., Shah, R. N., Jesudason, N. G., Taha, Y., Metadata curation, P. A. A. S. &. A., McHugh, M. P., Dewar, R., Metadata curation, S. &. L. A. S. &. A., Jahun, A. S., McMurray, C., Pandey, S., McKenna, J. P., Nelson, A., Young, G. R., McCann, C. M., Elliott, S., Metadata curation, S. &. L. A. V., Lowe, H., Metadata curation, S. &. A. A. S. &. A. T., Temperton, B., Roy, S., Price, A., Rey, S., Wyles, M., Metadata curation, S. &. A. A. V., Rooke, S., Shaaban, S., Project administration, S. &. L. A. S. &. A., de Cesare, M., Project administration, S. &. L. A. S. &. A. T., Letchford, L., Project administration, S. &. L. A. V., Silveira, S., Pelosi, E., Wilson-Davies, E., Samples & logistics, S. &. A. A. S. &. A. T., Hosmillo, M., Sequencing & analysis, S. &. A. T. A. V., O’Toole, Á., Hesketh, A. R., Stark, R., du Plessis, L., Ruis, C., Adams, H., Bourgeois, Y., supervision, F. A. A. L. &., Michell, S. L., Grammatopoulos, D., Edgeworth, J., Breuer, J., Todd, J. A., Fraser, C., Funding acquisition and project administration, Buck, D., John, M., curation, L. &. S. A. M., Kay, G. L., Leadership & supervision and project administration, Palmer, S., Peacock, S. J., Heyburn, D., logistics, L. &. S. A. S. &., Weldon, D., Robinson, E., McNally, A., Muir, P., Vipond, I. B., Boyes, J., Sivaprakasam, V., Salluja, T., Dervisevic, S., Meader, E. J., analysis, L. &. S. A. S. &., Park, N. R., Oliver, K., Jeffries, A. R., Ott, S., da Silva Filipe, A., Simpson, D. A., Williams, C., visualization, L. &. S. A., Masoli, J. A. H., logistics, M. C. A. S. &., Knight, B. A., Jones, C. R., Koshy, C., Ash, A., Casey, A., Bosworth, A., Ratcliffe, L., Xu-McCrae, L., Pymont, H. M., Hutchings, S., Berry, L., Jones, K., Halstead, F., Davis, T., Holmes, C., Iturriza-Gomara, M., Lucaci, A. O., Randell, P. A., Cox, A., Madona, P., Harris, K. A., Brown, J. R., Mahungu, T. W., Irish-Tavares, D., Haque, T., Hart, J., Witele, E., Fenton, M. L., Liggett, S., Graham, C., Swindells, E., Collins, J., Eltringham, G., Campbell, S., McClure, P. C., Clark, G., Sloan, T. J., Jones, C., Lynch, J., analysis, M. C. A. S. &., Warne, B., Leonard, S., Durham, J., Williams, T., Haldenby, S. T., Storey, N., Alikhan, N.-F., Holmes, N., Moore, C., Carlile, M., Perry, M., Craine, N., Lyons, R. A., Beckett, A. H., Goudarzi, S., Fearn, C., Cook, K., Dent, H., Paul, H., tools, M. C. A. S. &. A., Davies, R., Project administration and samples & logistics, Blane, B., Girgis, S. T., Beale, M. A., Bellis, K. L., Dorman, M. J., Drury, E., Kane, L., Kay, S., McGuigan, S., Nelson, R., Prestwood, L., Rajatileka, S., Batra, R., Williams, R. J., Kristiansen, M., Green, A., Justice, A., Mahanama, A. I. K., Samaraweera, B., Project administration and sequencing & analysis, Hadjirin, N. F., Quick, J., Project administration and software & analysis tools, Poplawski, R., analysis, S. &. L. A. S. &., Kermack, L. M., Reynolds, N., Hall, G., Chaudhry, Y., Pinckert, M. L., Georgana, I., Moll, R. J., Thornton, A., Myers, R., Stockton, J., Williams, C. A., Yew, W. C., Trotter, A. J., Trebes, A., MacIntyre-Cockett, G., Birchley, A., Adams, A., Plimmer, A., Gatica-Wilcox, B., McKerr, C., Hilvers, E., Jones, H., Asad, H., Coombes, J., Evans, J. M., Fina, L., Gilbert, L., Graham, L., Cronin, M., Kumziene-Summerhayes, S., Taylor, S., Jones, S., Groves, D. C., Zhang, P., Gallis, M., Louka, S. F., tools, S. &. L. A. S. &. A., Starinskij, I., tools, S. &. A. A. S. &. A., Jackson, C., Gourtovaia, M., Tonkin-Hill, G., Lewis, K., Tovar-Corona, J. M., James, K., Baxter, L., Alam, M. T., Orton, R. J., Hughes, J., Vattipally, S., Ragonnet-Cronin, M., Nascimento, F. F., Jorgensen, D., Boyd, O., Geidelberg, L., Zarebski, A. E., Raghwani, J., Kraemer, M. U. G., Southgate, J., Lindsey, B. B., Freeman, T. M., visualization, S. &. A. T. A., Keatley, J.-P., Singer, J. B., de Oliveira Martins, L., Yeats, C. A., Abudahab, K., Taylor, B. E. W., Menegazzo, M., supervision, L. &., Danesh, J., Hogsden, W., Eldirdiri, S., Kenyon, A., Mason, J., Robinson, T. I., Holmes, A., Price, J., Hartley, J. A., Curran, T., Mather, A. E., Shankar, G., Jones, R., Howe, R., Morgan, S., curation, M., Wastenge, E., Chapman, M. R., Mookerjee, S., Stanley, R., Smith, W., Peto, T., Eyre, D., Crook, D., Vernet, G., Kitchen, C., Gulliver, H., Merrick, I., Guest, M., Munn, R., Bradley, D. T., Wyatt, T., Project administration, Beaver, C., Foulser, L., Palmer, S., Churcher, C. M., Brooks, E., Smith, K. S., Galai, K., McManus, G. M., Bolt, F., Coll, F., Meadows, L., Attwood, S. W., Davies, A., De Lacy, E., Downing, F., Edwards, S., Scarlett, G. P., Jeremiah, S., Smith, N., logistics, S. &., Leek, D., Sridhar, S., Forrest, S., Cormie, C., Gill, H. K., Dias, J., Higginson, E. E., Maes, M., Young, J., Wantoch, M., Jamrozy, D., Lo, S., Patel, M., Hill, V., Bewshea, C. M., Ellard, S., Auckland, C., Harrison, I., Bishop, C., Chalker, V., Richter, A., Beggs, A., Best, A., Percival, B., Mirza, J., Megram, O., Mayhew, M., Crawford, L., Ashcroft, F., Moles-Garcia, E., Cumley, N., Hopes, R., Asamaphan, P., Niebel, M. O., Gunson, R. N., Bradley, A., Maclean, A., Mollett, G., Blacow, R., Bird, P., Helmer, T., Fallon, K., Tang, J., Hale, A. D., Macfarlane-Smith, L. R., Harper, K. L., Carden, H., Machin, N. W., Jackson, K. A., Ahmad, S. S. Y., George, R. P., Turtle, L., O’Toole, E., Watts, J., Breen, C., Cowell, A., Alcolea-Medina, A., Charalampous, T., Patel, A., Levett, L. J., Heaney, J., Rowan, A., Taylor, G. P., Shah, D., Atkinson, L., Lee, J. C. D., Westhorpe, A. P., Jannoo, R., Lowe, H. L., Karamani, A., Ensell, L., Chatterton, W., Pusok, M., Dadrah, A., Symmonds, A., Sluga, G., Molnar, Z., Baker, P., Bonner, S., Essex, S., Barton, E., Padgett, D., Scott, G., Greenaway, J., Payne, B. A. I., Burton-Fanning, S., Waugh, S., Raviprakash, V., Sheriff, N., Blakey, V., Williams, L.-A., Moore, J., Stonehouse, S., Smith, L., Davidson, R. K., Bedford, L., Coupland, L., Wright, V., Chappell, J. G., Tsoleridis, T., Ball, J., Khakh, M., Fleming, V. M., Lister, M. M., Howson-Wells, H. C., Berry, L., Boswell, T., Joseph, A., Willingham, I., Duckworth, N., Walsh, S., Wise, E., Moore, N., Mori, M., Cortes, N., Kidd, S., Williams, R., Gifford, L., Bicknell, K., Wyllie, S., Lloyd, A., Impey, R., Malone, C. S., Cogger, B. J., Levene, N., Monaghan, L., Keeley, A. J., Partridge, D. G., Raza, M., Evans, C., Johnson, K., Abnizova, I., Aigrain, L., Alderton, A., Ali, M., Allen, L., Amato, R., Anderson, R., Ariani, C., Austin-Guest, S., Bala, S., Barrett, J., Bassett, A., Battleday, K., Beal, J., Beale, M., Beaver, C., Bellany, S., Bellerby, T., Bellis, K., Berger, D., Berriman, M., Betteridge, E., Bevan, P., Binley, S., Bishop, J., Blackburn, K., Bonfield, J., Boughton, N., Bowker, S., Brendler-Spaeth, T., Bronner, I., Brooklyn, T., Buddenborg, S. K., Bush, R., Caetano, C., Cagan, A., Carter, N., Cartwright, J., Monteiro, T. C., Chapman, L., Chillingworth, T.-J., Clapham, P., Clark, R., Clarke, A., Clarke, C., Cole, D., Cook, E., Coppola, M., Cornell, L., Cornwell, C., Corton, C., Crackett, A., Cranage, A., Craven, H., Craw, S., Crawford, M., Cutts, T., Dabrowska, M., Davies, M., Davies, R., Dawson, J., Day, C., Densem, A., Dibling, T., Dockree, C., Dodd, D., Dogga, S., Dorman, M., Dougan, G., Dougherty, M., Dove, A., Drummond, L., Drury, E., Dudek, M., Durham, J., Durrant, L., Easthope, E., Eckert, S., Ellis, P., Farr, B., Fenton, M., Ferrero, M., Flack, N., Fordham, H., Forsythe, G., Foulser, L., Francis, M., Fraser, A., Freeman, A., Galvin, A., Garcia-Casado, M., Gedny, A., Girgis, S., Glover, J., Goncalves, S., Goodwin, S., Gould, O., Gourtovaia, M., Gray, A., Gray, E., Griffiths, C., Gu, Y., Guerin, F., Hamilton, W., Hanks, H., Harrison, E., Harrott, A., Harry, E., Harvison, J., Heath, P., Hernandez-Koutoucheva, A., Hobbs, R., Holland, D., Holmes, S., Hornett, G., Hough, N., Huckle, L., Hughes-Hallet, L., Hunter, A., Inglis, S., Iqbal, S., Jackson, A., Jackson, D., James, K., Jamrozy, D., Verdejo, C. J., Johnston, I., Jones, M., Kallepally, K., Kane, L., Kay, K., Kay, S., Keatley, J., Keith, A., King, A., Kitchin, L., Kleanthous, M., Klimekova, M., Korlevic, P., Krasheninnkova, K., Kwiatkowski, D., Lane, G., Langford, C., Laverack, A., Law, K., Lawniczak, M., Lensing, S., Leonard, S., Letchford, L., Lewis, K., Lewis-Wade, A., Liddle, J., Lin, Q., Lindsay, S., Linsdell, S., Livett, R., Lo, S., Long, R., Lovell, J., Lovell, J., Ludden, C., Mack, J., Maddison, M., Makunin, A., Mamun, I., Mansfield, J., Marriott, N., Martin, M., Martincorena, I., Mayho, M., McCarthy, S., McClintock, J., McGuigan, S., McHugh, S., McMinn, L., Meadows, C., Mobley, E., Moll, R., Morra, M., Morrow, L., Murie, K., Nash, S., Nathwani, C., Naydenova, P., Neaverson, A., Nelson, R., Nerou, E., Nicholson, J., Nimz, T., Noell, G. G., O’Meara, S., Ohan, V., Oliver, K., Olney, C., Ormond, D., Oszlanczi, A., Palmer, S., Pang, Y. F., Pardubska, B., Park, N., Parmar, A., Patel, G., Patel, M., Payne, M., Peacock, S., Petersen, A., Plowman, D., Preston, T., Prestwood, L., Puethe, C., Quail, M., Rajan, D., Rajatileka, S., Rance, R., Rawlings, S., Redshaw, N., Reynolds, J., Reynolds, M., Rice, S., Richardson, M., Roberts, C., Robinson, K., Robinson, M., Robinson, D., Rogers, H., Rojo, E. M., Roopra, D., Rose, M., Rudd, L., Sadri, R., Salmon, N., Saul, D., Schwach, F., Scott, C., Seekings, P., Shirley, L., Sillitoe, J., Simms, A., Sinnott, M., Sivadasan, S., Siwek, B., Sizer, D., Skeldon, K., Skelton, J., Slater-Tunstill, J., Sloper, L., Smerdon, N., Smith, C., Smith, C., Smith, J., Smith, K., Smith, M., Smith, S., Smith, T., Sneade, L., Soria, C. D., Sousa, C., Souster, E., Sparkes, A., Spencer-Chapman, M., Squares, J., Stanley, R., Steed, C., Stickland, T., Still, I., Stratton, M., Strickland, M., Swann, A., Swiatkowska, A., Sycamore, N., Swift, E., Symons, E., Szluha, S., Taluy, E., Tao, N., Taylor, K., Taylor, S., Thompson, S., Thompson, M., Thomson, M., Thomson, N., Thurston, S., Tonkin-Hill, G., Toombs, D., Topping, B., Tovar-Corona, J., Ungureanu, D., Uphill, J., Urbanova, J., Jansen Van, P., Vancollie, V., Voak, P., Walker, D., Walker, M., Waller, M., Ward, G., Weatherhogg, C., Webb, N., Weldon, D., Wells, A., Wells, E., Westwood, L., Whipp, T., Whiteley, T., Whitton, G., Whitwham, A., Widaa, S., Williams, M., Wilson, M., Wright, S., analysis, S. &., Betteridge, E., Farr, B. W., Goodwin, S., Quail, M. A., Scott, C., Shirley, L., Thurston, S. A. J., Rajan, D., Bronner, I. F., Aigrain, L., Redshaw, N. M., Lensing, S. V., McCarthy, S., Makunin, A., Balcazar, C. E., Gallagher, M. D., Williamson, K. A., Stanton, T. D., Michelsen, M. L., Warwick-Dugdale, J., Manley, R., Farbos, A., Harrison, J. W., Sambles, C. M., Studholme, D. J., Lackenby, A., Mbisa, T., Platt, S., Miah, S., Bibby, D., Manso, C., Hubb, J., Dabrera, G., Ramsay, M., Bradshaw, D., Schaefer, U., Groves, N., Gallagher, E., Lee, D., Williams, D., Ellaby, N., Hartman, H., Manesis, N., Patel, V., Ledesma, J., Twohig, K. A., Allara, E., Pearson, C., Cheng, J. K. J., Bridgewater, H. E., Frost, L. R., Taylor-Joyce, G., Brown, P. E., Tong, L., Broos, A., Mair, D., Nichols, J., Carmichael, S. N., Smollett, K. L., Nomikou, K., Aranday-Cortes, E., Johnson, N., Nickbakhsh, S., Vamos, E. E., Hughes, M., Rainbow, L., Eccles, R., Nelson, C., Whitehead, M., Gregory, R., Gemmell, M., Wierzbicki, C., Webster, H. J., Fisher, C. L., Signell, A. W., Betancor, G., Wilson, H. D., Nebbia, G., Flaviani, F., Cerda, A. C., Merrill, T. V., Wilson, R. E., Cotic, M., Bayzid, N., Thompson, T., Acheson, E., Rushton, S., O’Brien, S., Baker, D. J., Rudder, S., Aydin, A., Sang, F., Debebe, J., Francois, S., Vasylyeva, T. I., Zamudio, M. E., Gutierrez, B., Marchbank, A., Maksimovic, J., Spellman, K., McCluggage, K., Morgan, M., Beer, R., Afifi, S., Workman, T., Fuller, W., Bresner, C., Angyal, A., Green, L. R., Parsons, P. J., Tucker, R. M., Brown, R., Whiteley, M., tools, S. &. A., Bonfield, J., Puethe, C., Whitwham, A., Liddle, J., Rowe, W., Siveroni, I., Le-Viet, T., Gaskin, A., Visualization, Johnson, R., Sharrocks, K., Blane, E., Modis, Y., Leigh, K. E., Briggs, J. A. G., van Gils, M. J., Smith, K. G. C., Bradley, J. R., Smith, C., Doffinger, R., Ceron-Gutierrez, L., Barcenas-Morales, G., Pollock, D. D., Goldstein, R. A., Smielewska, A., Skittrall, J. P., Gouliouris, T., Goodfellow, I. G., Gkrania-Klotsas, E., Illingworth, C. J. R., McCoy, L. E., & Gupta, R. K.
- Affiliations
- University College London (GB)
- University of Cambridge (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- NHS Blood and Transplant (GB)
- Medway School of Pharmacy (GB)
- University of Basel (CH)
- Addenbrooke's Hospital (GB)
- Papworth Hospital NHS Foundation Trust (GB)
- Fulbourn Hospital (GB)
- Murdoch University (AU)
- King's College London (GB)
- Public Health Wales (GB)
- Wellcome Sanger Institute (GB)
- University of Oxford (GB)
- University of Brighton (GB)
- Guy's Hospital (GB)
- University Hospital Southampton NHS Foundation Trust (GB)
- St Thomas' Hospital (GB)
- Belfast Health and Social Care Trust (GB)
- East Kent Hospitals University NHS Foundation Trust (GB)
- University of Birmingham (GB)
- Public Health England (GB)
- University of Sheffield (GB)
- University of Nottingham (GB)
- Northumbria University (GB)
- Queen's University Belfast (GB)
- University of Kent (GB)
- Quadram Institute (GB)
- Public Health Scotland (GB)
- Portsmouth Hospitals NHS Trust (GB)
- University of Liverpool (GB)
- Imperial College London (GB)
- MRC University of Glasgow Centre for Virus Research (GB)
- NHS Lothian (GB)
- University Hospitals Coventry and Warwickshire NHS Trust (GB)
- University of East Anglia (GB)
- University of Exeter (GB)
- Brighton and Sussex University Hospitals NHS Trust (GB)
- Betsi Cadwaladr University Health Board (GB)
- Centre for Human Genetics (GB)
- Cardiff and Vale University Health Board (GB)
- Gloucestershire Hospitals NHS Foundation Trust (GB)
- Sandwell & West Birmingham Hospitals NHS Trust (GB)
- Norfolk and Norwich University Hospital (GB)
- University of Warwick (GB)
- Barking, Havering And Redbridge University Hospitals NHS Trust (GB)
- Queen Elizabeth Hospital Birmingham (GB)
- Wye Valley NHS Trust (GB)
- University Hospitals of Leicester NHS Trust (GB)
- Great Ormond Street Hospital (GB)
- Royal Free London NHS Foundation Trust (GB)
- South Tees Hospitals NHS Foundation Trust (GB)
- North Cumbria Integrated Care NHS Foundation Trust (GB)
- North Tees and Hartlepool NHS Foundation Trust (GB)
- County Durham and Darlington NHS Foundation Trust (GB)
- Basingstoke and North Hampshire Hospital (GB)
- University of Portsmouth (GB)
- Kettering General Hospital (GB)
- North West London Pathology (GB)
- University of Surrey (GB)
- Swansea University (GB)
- Royal Hampshire County Hospital (GB)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Royal Devon & Exeter NHS Foundation Trust (GB)
- National Institute for Health and Care Research (GB)
- NHS Greater Glasgow and Clyde (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Maidstone and Tunbridge Wells NHS Trust (GB)
- University of Edinburgh (GB)
- Norfolk County Council (GB)
- East Suffolk and North Essex NHS Foundation Trust (GB)
- Queen's Medical Centre (GB)
- Manchester University NHS Foundation Trust (GB)
- Princess Alexandra Hospital NHS Trust (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- MRC Laboratory of Molecular Biology (GB)
- Amsterdam UMC Location University of Amsterdam (NL)
- Facultad de Estudios Superiores Cuautitlán (MX)
- Newcastle University (GB)
- Cardiff University (GB)
- University of Colorado Anschutz (US)
- Corresponding author
- Gupta, Ravindra K.
- ORCID
- Kemp, Steven A.
- Collier, Dami A.
- Datir, Rawlings P.
- Ferreira, Isabella A. T. M.
- Jahun, Aminu
- Rees-Spear, Chloe
- Roberts, David J.
- Chandra, Anita
- Temperton, Nigel
- Baker, Stephen
- Hess, Christoph
- Kingston, Nathalie
- Lehner, Paul J.
- Lyons, Paul A.
- Matheson, Nicholas J.
- Summers, Charlotte
- Thaventhiran, James E. D.
- Toshner, Mark
- Weekes, Michael P.
- Domingo, Jason
- Kennet, Jane
- Price, Jane
- Rowlands, Jane
- Dunmore, Benjamin J.
- Gräf, Stefan
- Legchenko, Ekaterina
- Martin, Jennifer
- Mescia, Federica
- Pointon, Linda
- Tilly, Tobias
- Wood, Jennifer
- Cossetti, Chiara
- Epping, Madeline
- Grenfell, Richard
- Jackson, Sarah
- Nice, Francesca
- Omarjee, Ommar
- Perera, Marianne
- Richoz, Nathan
- Yarkoni, Natalia Savinykh
- Sharma, Rahul
- Stefanucci, Luca
- Stephens, Jonathan
- Bunclark, Katherine
- Rossi, Sabrina
- Yong, Cissy
- Ansaripour, Ali
- Mwaura, Lucy
- Polwarth, Gary
- Polgarova, Petra
- Bong, Sze-How
- Holmes, Elaine
- Papadia, Sofia
- Stark, Hannah
- Stirrups, Kathleen E.
- Walker, Neil
- Webster, Jennifer
- Robson, Samuel C.
- Loman, Nicholas J.
- Connor, Thomas R.
- Golubchik, Tanya
- Bonsall, David
- Smith, Colin P.
- Bucca, Giselda
- Saeed, Kordo
- Prieto, Jacqui A.
- Snell, Luke B.
- Moore, Catherine
- Fairley, Derek J.
- Loose, Matthew W.
- Moses, Samuel
- Bull, Matthew
- Aanensen, David M.
- Curran, Martin D.
- Parmar, Surendra
- Aggarwal, Dinesh
- Shepherd, James G.
- Glaysher, Sharon
- Bashton, Matthew
- Pacchiarini, Nicole
- Carabelli, Alessandro M.
- Templeton, Kate E.
- Wang, Dennis
- Rambaut, Andrew
- O’Grady, Justin
- Cottrell, Simon
- Holden, Matthew T. G.
- Thomson, Emma C.
- Andersson, Monique
- Chauhan, Anoop J.
- Chand, Meera
- Constantinidou, Chrystala
- Unnikrishnan, Meera
- Darby, Alistair C.
- Hiscox, Julian A.
- Paterson, Steve
- Robertson, David L.
- Volz, Erik M.
- Page, Andrew J.
- Pybus, Oliver G.
- Li, Kathy K.
- Shah, Rajiv N.
- Jesudason, Natasha G.
- Dewar, Rebecca
- McMurray, Claire
- McKenna, James P.
- Nelson, Andrew
- Young, Gregory R.
- McCann, Clare M.
- Temperton, Ben
- Roy, Sunando
- Price, Anna
- Rey, Sara
- Rooke, Stefan
- Shaaban, Sharif
- Silveira, Siona
- Pelosi, Emanuela
- Wilson-Davies, Eleri
- Stark, Richard
- Bourgeois, Yann
- Grammatopoulos, Dimitris
- Edgeworth, Jonathan
- Breuer, Judith
- Todd, John A.
- Fraser, Christophe
- Buck, David
- Kay, Gemma L.
- McNally, Alan
- Muir, Peter
- Sivaprakasam, Venkat
- Dervisevic, Samir
- Jeffries, Aaron R.
- Ott, Sascha
- Simpson, David A.
- Masoli, Jane A. H.
- Knight, Bridget A.
- Jones, Christopher R.
- Bosworth, Andrew
- Pymont, Hannah M.
- Hutchings, Stephanie
- Jones, Katie
- Halstead, Fenella
- Holmes, Christopher
- Randell, Paul Anthony
- Cox, Alison
- Harris, Kathryn Ann
- Brown, Julianne Rose
- Haque, Tanzina
- Liggett, Steven
- Graham, Clive
- Collins, Jennifer
- Clark, Gemma
- Sloan, Tim J.
- Lynch, Jessica
- Warne, Ben
- Williams, Thomas
- Haldenby, Sam T.
- Storey, Nathaniel
- Alikhan, Nabil-Fareed
- Holmes, Nadine
- Perry, Malorie
- Lyons, Ronan A.
- Beckett, Angela H.
- Fearn, Christopher
- Cook, Kate
- Blane, Beth
- Batra, Rahul
- Williams, Rachel J.
- Green, Angie
- Samaraweera, Buddhini
- Quick, Joshua
- Poplawski, Radoslaw
- Reynolds, Nicola
- Hall, Grant
- Chaudhry, Yasmin
- Pinckert, Malte L.
- Georgana, Iliana
- Myers, Richard
- Stockton, Joanne
- Williams, Charlotte A.
- Yew, Wen C.
- Trotter, Alexander J.
- Trebes, Amy
- Plimmer, Amy
- McKerr, Caoimhe
- Asad, Hibo
- Graham, Lee
- Taylor, Sarah
- Gallis, Marta
- Louka, Stavroula F.
- Starinskij, Igor
- Jackson, Chris
- Baxter, Laura
- Alam, Mohammad T.
- Orton, Richard J.
- Hughes, Joseph
- Jorgensen, David
- Geidelberg, Lily
- Zarebski, Alex E.
- Raghwani, Jayna
- Kraemer, Moritz U. G.
- Southgate, Joel
- Lindsey, Benjamin B.
- Singer, Joshua B.
- Yeats, Corin A.
- Taylor, Ben E. W.
- Danesh, John
- Eldirdiri, Sahar
- Holmes, Alison
- Price, James
- Hartley, John A.
- Mather, Alison E.
- Chapman, Michael R.
- Mookerjee, Siddharth
- Stanley, Rachael
- Eyre, David
- Crook, Derrick
- Vernet, Gabrielle
- Merrick, Ian
- Bradley, Declan T.
- Bolt, Frances
- Coll, Francesc
- Attwood, Stephen W.
- Davies, Alisha
- Scarlett, Garry P.
- Leek, Danielle
- Sridhar, Sushmita
- Cormie, Claire
- Higginson, Ellen E.
- Maes, Mailis
- Young, Jamie
- Wantoch, Michelle
- Hill, Verity
- Bewshea, Claire M.
- Ellard, Sian
- Auckland, Cressida
- Harrison, Ian
- Richter, Alex
- Beggs, Andrew
- Best, Angus
- Percival, Benita
- Mirza, Jeremy
- Megram, Oliver
- Mayhew, Megan
- Crawford, Liam
- Cumley, Nicola
- Asamaphan, Patawee
- Niebel, Marc O.
- Gunson, Rory N.
- Mollett, Guy
- Blacow, Rachel
- Bird, Paul
- Tang, Julian
- Carden, Holli
- Jackson, Kathryn A.
- Ahmad, Shazaad S. Y.
- Turtle, Lance
- Alcolea-Medina, Adela
- Charalampous, Themoula
- Patel, Amita
- Rowan, Aileen
- Taylor, Graham P.
- Shah, Divya
- Atkinson, Laura
- Lee, Jack C. D.
- Westhorpe, Adam P.
- Lowe, Helen L.
- Ensell, Leah
- Baker, Paul
- Bonner, Stephen
- Essex, Sarah
- Payne, Brendan A. I.
- Raviprakash, Veena
- Smith, Louise
- Davidson, Rose K.
- Bedford, Luke
- Coupland, Lindsay
- Wright, Victoria
- Chappell, Joseph G.
- Tsoleridis, Theocharis
- Ball, Jonathan
- Lister, Michelle M.
- Joseph, Amelia
- Willingham, Iona
- Walsh, Sarah
- Wise, Emma
- Moore, Nathan
- Mori, Matilde
- Kidd, Stephen
- Williams, Rebecca
- Bicknell, Kelly
- Wyllie, Sarah
- Keeley, Alexander J.
- Partridge, David G.
- Raza, Mohammad
- Evans, Cariad
- Johnson, Kate
- Abnizova, Irina
- Barrett, Jeffrey
- Bellis, Katie
- Berger, Duncan
- Blackburn, Kirsty
- Buddenborg, Sarah Kay
- Cagan, Alex
- Clark, Richard
- Cook, Elizabeth
- Coppola, Maria
- Corton, Craig
- Crawford, Mark
- Dogga, Sunil
- Gray, Emma
- Harrott, Alexandria
- Harry, Edward
- Heath, Paul
- Holmes, Sarah
- Iqbal, Sameena
- Jones, Matthew
- Keatley, Jon
- Langford, Cordelia
- Liddle, Jennifer
- Lin, Quan
- Lindsay, Sarah
- Mayho, Matthew
- Murie, Kathryn
- Naydenova, Plamena
- Noell, Guillaume G.
- Ohan, Valeriu
- Patel, Gaurang
- Plowman, Deborah
- Robinson, Katrina
- Robinson, David
- Rogers, Hazel
- Schwach, Frank
- Skeldon, Kenneth
- Smith, James
- Smith, Michelle
- Smith, Sean
- Strickland, Michelle
- Thomson, Nicholas
- Thurston, Scott
- Vancollie, Valerie
- Walker, Matthew
- Waller, Matt
- Wells, Eloise
- Whitton, Georgia
- Widaa, Sara
- Williams, Mia
- Makunin, Alex
- Williamson, Kathleen A.
- Warwick-Dugdale, Joanna
- Farbos, Audrey
- Harrison, James W.
- Sambles, Christine M.
- Studholme, David J.
- Lackenby, Angie
- Miah, Shahjahan
- Bibby, David
- Hubb, Jonathan
- Dabrera, Gavin
- Ramsay, Mary
- Bradshaw, Daniel
- Groves, Natalie
- Gallagher, Eileen
- Lee, David
- Ellaby, Nicholas
- Hartman, Hassan
- Ledesma, Juan
- Twohig, Katherine A.
- Allara, Elias
- Cheng, Jeffrey K. J.
- Bridgewater, Hannah E.
- Frost, Lucy R.
- Brown, Paul E.
- Tong, Lily
- Broos, Alice
- Mair, Daniel
- Nichols, Jenna
- Carmichael, Stephen N.
- Smollett, Katherine L.
- Nomikou, Kyriaki
- Eccles, Richard
- Whitehead, Mark
- Gemmell, Matthew
- Wierzbicki, Claudia
- Webster, Hermione J.
- Signell, Adrian W.
- Betancor, Gilberto
- Wilson, Harry D.
- Nebbia, Gaia
- Flaviani, Flavia
- Cotic, Marius
- Bayzid, Nadua
- Thompson, Thomas
- O’Brien, Sarah
- Baker, David J.
- Rudder, Steven
- Aydin, Alp
- Sang, Fei
- Debebe, Johnny
- Vasylyeva, Tetyana I.
- Marchbank, Angela
- Morgan, Mari
- Workman, Trudy
- Fuller, William
- Bresner, Catherine
- Angyal, Adrienn
- Green, Luke R.
- Parsons, Paul J.
- Tucker, Rachel M.
- Brown, Rebecca
- Whiteley, Max
- Siveroni, Igor
- Le-Viet, Thanh
- Sharrocks, Katherine
- Modis, Yorgo
- Leigh, Kendra E.
- Briggs, John A. G.
- Smith, Kenneth G. C.
- Bradley, John R.
- Pollock, David D.
- Goldstein, Richard A.
- Smielewska, Anna
- Skittrall, Jordan P.
- Gouliouris, Theodore
- Goodfellow, Ian G.
- Gkrania-Klotsas, Effrossyni
- Illingworth, Christopher J. R.
- McCoy, Laura E.
- Gupta, Ravindra K.
- Venue
- Nature
- Published
- 2021-02-05
- Volume
- 592
- Issue
- 7853
- Pages
- 277-282
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7610568
- OpenAlex
- W3128154910
- Cited by
- 1,097
- References
- 54
- Citations by year
- 2026: 36 · 2025: 72 · 2024: 121 · 2023: 157 · 2022: 283 · 2021: 411
- FWCI
- 77.05
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-07-21)
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- PubMed Central (acceptedVersion)
- Kent Academic Repository (University of Kent) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Europe PMC (PubMed Central) (submittedVersion, cc-by-nc-nd)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion, cc-by-sa)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- Bill and Melinda Gates Foundation (OPP 1175094)
- Wellcome Trust (108082/A/15/Z, 108082, 204911/Z/16/Z, Z/17/Z, WT108082AIA, 217191, 206618/Z/17/Z, 207498, 207498/Z/17/Z)
- UK Research and Innovation (MC_UU_00002/11)
- Cancer Research UK (23923)
- National Institute for Health and Care Research (NF-SI-0514-10109, 207498, RP-PG-0514-20018, ACF-2017-15-004, ACF-2018-04-014, COVID-19-RECPLAS)
- Academy of Medical Sciences (AMS-CSF4-Torok)
- National Institutes of Health (COVID-19)
- NIHR BioResource
- Medical Research Council (MC_UU_00002/11, MR/R015600/1, MR/R008698/1, COVID-19, MC_UP_1201/16)
- Biotechnology and Biological Sciences Research Council (BBS/E/F/000PR10348, BB/P007562/1)
- NIHR Cambridge Biomedical Research Centre
- National Institute of General Medical Sciences (R01GM083127)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- SARS-CoV-2, chronic infection, viral evolution, spike protein, convalescent plasma therapy, neutralizing antibodies, antibody escape, remdesivir, immunosuppression, viral selection, viral infectivity, ultra-deep sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
